PL3022297T3 - Stabilny genetycznie onkolityczny wirus rna, sposób jego wytwarzania i zastosowanie - Google Patents

Stabilny genetycznie onkolityczny wirus rna, sposób jego wytwarzania i zastosowanie

Info

Publication number
PL3022297T3
PL3022297T3 PL14747317.7T PL14747317T PL3022297T3 PL 3022297 T3 PL3022297 T3 PL 3022297T3 PL 14747317 T PL14747317 T PL 14747317T PL 3022297 T3 PL3022297 T3 PL 3022297T3
Authority
PL
Poland
Prior art keywords
manufacturing
rna virus
genetically stable
oncolytic rna
stable oncolytic
Prior art date
Application number
PL14747317.7T
Other languages
English (en)
Inventor
Dite Venskus
Ivars Kalvins
Dace Pjanova
Ramona Petrovska
Jurgis Auzins
Original Assignee
Ditesan Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ditesan Ltd. filed Critical Ditesan Ltd.
Publication of PL3022297T3 publication Critical patent/PL3022297T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14747317.7T 2013-07-16 2014-07-16 Stabilny genetycznie onkolityczny wirus rna, sposób jego wytwarzania i zastosowanie PL3022297T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13176757.6A EP2826856B9 (en) 2013-07-16 2013-07-16 Genetically stable oncolytic RNA virus, method of manufacturing and use thereof
PCT/EP2014/065277 WO2015007788A1 (en) 2013-07-16 2014-07-16 Genetically stable oncolytic rna virus, method of manufacturing and use thereof

Publications (1)

Publication Number Publication Date
PL3022297T3 true PL3022297T3 (pl) 2023-12-18

Family

ID=48790285

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13176757T PL2826856T3 (pl) 2013-07-16 2013-07-16 Genetycznie stabilny onkolityczny wirus RNA, sposób jego wytwarzania i zastosowanie
PL14747317.7T PL3022297T3 (pl) 2013-07-16 2014-07-16 Stabilny genetycznie onkolityczny wirus rna, sposób jego wytwarzania i zastosowanie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13176757T PL2826856T3 (pl) 2013-07-16 2013-07-16 Genetycznie stabilny onkolityczny wirus RNA, sposób jego wytwarzania i zastosowanie

Country Status (15)

Country Link
US (2) US10174291B2 (pl)
EP (2) EP2826856B9 (pl)
JP (1) JP6293882B2 (pl)
CN (2) CN105518128B (pl)
AU (1) AU2014292114B2 (pl)
BR (1) BR112016000874B1 (pl)
CA (1) CA2917584C (pl)
EA (1) EA032977B1 (pl)
ES (1) ES2566146T3 (pl)
GE (1) GEP201706763B (pl)
MD (1) MD4480C1 (pl)
MX (1) MX365075B (pl)
PL (2) PL2826856T3 (pl)
UA (1) UA116387C2 (pl)
WO (1) WO2015007788A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109276580B (zh) * 2017-07-21 2021-08-24 厦门大学 一种用于治疗肿瘤的病毒
CN109419818B (zh) * 2017-08-24 2021-08-10 厦门大学 一种用于治疗肿瘤的埃可病毒
CN107669707A (zh) * 2017-11-16 2018-02-09 邹罡 埃可病毒作为溶瘤病毒在抗肿瘤中的应用
CN110064044B (zh) * 2018-01-20 2022-09-09 中国科学院武汉病毒研究所 一种肠道病毒71型的抑制剂及应用
GB201808500D0 (en) 2018-05-23 2018-07-11 Ditesan Ltd Virus and virus use
WO2020035423A1 (en) 2018-08-13 2020-02-20 Ditesan Ltd. Combination therapy of cancer by administrating echo-7 virus and a pharmaceutically effective anti-cancer drug

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987101A (en) 1988-12-16 1991-01-22 International Business Machines Corporation Method for providing improved insulation in VLSI and ULSI circuits
CN1244583A (zh) * 1998-08-12 2000-02-16 财团法人生物技术开发中心 本土性猪水泡病病毒与其变异株的制备方法及用途
IL148621A0 (en) * 1999-09-17 2002-09-12 Pro Virus Inc Oncolytic virus
AUPQ425699A0 (en) * 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
US6602862B1 (en) * 2000-09-19 2003-08-05 Merz Pharma Gmbh & Co., Kgaa 1-Amino-alkylcyclohexanes as trypanocidal agents
US20030040498A1 (en) * 2001-03-14 2003-02-27 Ansardi David Calvert Oncolytic RNA replicons
LV12861B (lv) * 2002-06-14 2002-10-20 Aina Muceniece Imūnstimulators ar pretaudzēja aktivitāti un tā iegūšanas paņēmiens
AU2002953436A0 (en) * 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
PT1620456E (pt) * 2003-04-18 2014-04-15 Biotech Synergy Inc Péptidos antigénicos hla-a2 associados a tumor e suas composições
EP1843773A4 (en) * 2005-01-17 2008-07-30 Viralytics Ltd METHOD AND COMPOSITION FOR TREATING NEOPLASIA
WO2008080003A2 (en) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Generation of oncolytic adenoviruses and uses thereof
WO2010009735A2 (en) * 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
CA2689707A1 (en) * 2009-11-16 2011-05-16 Jean-Simon Diallo Identification of the novel small molecule viral sensitizer vse1 using high-throughput screening

Also Published As

Publication number Publication date
EA032977B1 (ru) 2019-08-30
EP2826856A1 (en) 2015-01-21
UA116387C2 (uk) 2018-03-12
CN105518128B (zh) 2019-07-09
MX2016000462A (es) 2016-07-26
BR112016000874A2 (pt) 2017-03-21
US10435672B2 (en) 2019-10-08
US10174291B2 (en) 2019-01-08
MD4480B1 (ro) 2017-05-31
MD4480C1 (ro) 2017-12-31
BR112016000874B1 (pt) 2019-07-16
EP3022297C0 (en) 2023-07-05
CN110129284A (zh) 2019-08-16
MD20160014A2 (ro) 2016-07-31
CN105518128A (zh) 2016-04-20
AU2014292114A1 (en) 2016-02-18
MX365075B (es) 2019-05-22
EP3022297A1 (en) 2016-05-25
WO2015007788A1 (en) 2015-01-22
EP2826856B1 (en) 2015-12-23
US20160376562A1 (en) 2016-12-29
PL2826856T3 (pl) 2016-06-30
ES2566146T3 (es) 2016-04-11
JP2016529886A (ja) 2016-09-29
EA201690232A1 (ru) 2016-05-31
US20190144833A1 (en) 2019-05-16
JP6293882B2 (ja) 2018-03-14
EP3022297B1 (en) 2023-07-05
CA2917584C (en) 2018-02-27
CA2917584A1 (en) 2015-01-22
HK1219500A1 (en) 2017-04-07
AU2014292114B2 (en) 2018-12-20
GEP201706763B (en) 2017-10-25
EP2826856B9 (en) 2016-05-04

Similar Documents

Publication Publication Date Title
IL270877B (en) Hepatitis b virus inhibitory double-stranded rna,compositions comprising the same and uses thereof
ZA201802315B (en) Methods of preparing nicotinamide riboside and derivatives thereof
IL244697A0 (en) Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
IL244189B (en) Certain chemical entities, compositions, and methods
IL240881A0 (en) Expression of the t cell balance gene, preparations, materials and methods for its use
IL241294A0 (en) Genetic expression of response in dendritic cells, preparations and methods of use
HUE042640T2 (hu) CFTR-mRNS-készítmények, valamint kapcsolódó eljárások és alkalmazások
HUE054437T2 (hu) Anti-CGRP készítmények és alkalmazásuk
IL241120A0 (en) Newcastle disease viruses and their use
IL243672A0 (en) Circulation and amplification of ligase-assisted nucleic acids
PL3459965T3 (pl) Sposoby przewidywania sekwencji wirusa-przodka i ich zastosowania
IL240936B (en) Reassortment of influenza virus and methods for their preparation
ZA201509229B (en) Influenza virus vaccines and uses thereof
EP3085784A4 (en) Nucleic acid inducing rna interference modified for preventing off-target, and use thereof
GB201319878D0 (en) Method, Array and use thereof
SG11201510209SA (en) Cell populations, methods of transdifferention and methods of use thereof
SG11201504771RA (en) Host cells and methods of use
PL3022297T3 (pl) Stabilny genetycznie onkolityczny wirus rna, sposób jego wytwarzania i zastosowanie
PL2988764T3 (pl) Kompozycje przeciwłupieżowe i sposoby ich zastosowania
DK2888100T3 (da) Fremstillingsfremgangsmåde, fremstillingsform og anvendelse
DK2805954T3 (da) 7-substitueret hanfangichin b-derivat, og fremstillingsfremgangsmåde og anvendelse deraf
BR112015004419A2 (pt) artigo e método.
IL245363A0 (en) Cell lines and processes for viral vector manufacture
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
EP3242932A4 (en) Employing human adipose-derived stem cells to propagate serum-derived hepatitis c virus and use thereof